$242 Million is the total value of Endurant Capital Management LP's 73 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RAD | Exit | RITE AID CORP | $0 | – | -17,700 | -100.0% | -0.05% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -12,026 | -100.0% | -0.06% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -8,400 | -100.0% | -0.08% | – |
| ANIP | Exit | ANI PHARMACEUTICALS INC | $0 | – | -4,600 | -100.0% | -0.11% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -84,443 | -100.0% | -0.12% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -5,100 | -100.0% | -0.12% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -6,300 | -100.0% | -0.13% | – |
| TSRO | Exit | TESARO INC | $0 | – | -3,400 | -100.0% | -0.13% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -10,500 | -100.0% | -0.13% | – |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -24,400 | -100.0% | -0.13% | – | |
| NLNK | Exit | NEWLINK GENETICS CORP | $0 | – | -29,791 | -100.0% | -0.17% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -5,150 | -100.0% | -0.17% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -26,040 | -100.0% | -0.18% | – |
| KITE | Exit | KITE PHARMA INC | $0 | – | -9,800 | -100.0% | -0.20% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -22,400 | -100.0% | -0.20% | – |
| KERX | Exit | KERYX BIOPHARMACEUTICALS INC | $0 | – | -116,000 | -100.0% | -0.23% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -3,470 | -100.0% | -0.23% | – |
| ALDR | Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -19,500 | -100.0% | -0.24% | – |
| NVLS | Exit | NIVALIS THERAPEUTICS INC | $0 | – | -85,412 | -100.0% | -0.26% | – |
| PRXL | Exit | PAREXEL INTL CORP | $0 | – | -10,100 | -100.0% | -0.26% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -94,812 | -100.0% | -0.27% | – |
| CSLT | Exit | CASTLIGHT HEALTH INCcl b | $0 | – | -184,826 | -100.0% | -0.28% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -6,657 | -100.0% | -0.30% | – |
| GI | Exit | ENDOCHOICE HLDGS INC | $0 | – | -121,663 | -100.0% | -0.36% | – |
| BKD | Exit | BROOKDALE SR LIVING INC | $0 | – | -59,070 | -100.0% | -0.38% | – |
| FVE | Exit | FIVE STAR QUALITY CARE INC | $0 | – | -575,076 | -100.0% | -0.41% | – |
| XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -18,900 | -100.0% | -0.42% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -69,574 | -100.0% | -0.52% | – |
| PRGO | Exit | PERRIGO CO PLC | $0 | – | -15,100 | -100.0% | -0.52% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -30,585 | -100.0% | -0.53% | – |
| LHCG | Exit | LHC GROUP INC | $0 | – | -42,700 | -100.0% | -0.58% | – |
| CNMD | Exit | CONMED CORP | $0 | – | -39,500 | -100.0% | -0.59% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -20,810 | -100.0% | -0.61% | – |
| Exit | FLUIDIGM CORP DELnote 2.750% 2/0 | $0 | – | -4,161,000 | -100.0% | -0.93% | – | |
| AMAG | Exit | AMAG PHARMACEUTICALS INC | $0 | – | -114,980 | -100.0% | -1.04% | – |
| VWR | Exit | VWR CORP | $0 | – | -107,422 | -100.0% | -1.13% | – |
| AMSG | Exit | AMSURG CORP | $0 | – | -147,500 | -100.0% | -3.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.